Blake Insomnia Therapeutics Inc. Announces Submitting Clinical Trial Application for Phase II Clinical Testing
August 25, 2017 09:30 ET
|
Blake Insomnia Therapeutics, Inc.
NEW YORK, Aug. 25, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTCQB:BKIT), a New York based pharmaceutical company devoted to improving quality of life for people with insomnia, is...
Blake Insomnia Therapeutics Inc. Announces Appointment of Dr. Eric Leire to its Board of Directors
May 09, 2017 13:20 ET
|
Blake Insomnia Therapeutics, Inc.
NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTCQB:BKIT) a New York based pharmaceutical company is pleased to announce the appointment of Dr. Eric Leire to join CEO...
Blake Insomnia Therapeutics Inc. Closes Joint Venture with Sajo Consulting LLC
February 24, 2017 20:08 ET
|
Blake Insomnia Therapeutics, Inc.
NEW YORK, Feb. 25, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTCQB:BKIT) and Sajo Consulting LLC are pleased to announce completion of a joint venture agreement for the development...
Blake Insomnia Therapeutics Inc. Seeks Financing for Clinical Trials
January 17, 2017 08:30 ET
|
Blake Insomnia Therapeutics, Inc.
NEW YORK, Jan. 17, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTC:BKIT) is preparing to launch a fundraising drive to complete Phase II clinical testing of its patent-pending ZLX-1...